Internal Medicine, Nephrology · Dallas, TX
NPI
1417335951
Since 2015
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
3571 W Wheatland Rd Ste 101
Dallas, TX, 75237
Phone (972) 274-5555
Groups this clinician bills Medicare through
Medicare paid, 2024
$266K
4,127 services
Medicare patients, 2024
598
Average age 75
Drug cost, 2024
$2.7M
4,119 prescriptions
Company payments, 2025
$14K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eldrid A Baez Matos was code 99458 (e&m - miscellaneous), 903 times for 75 patients. In total Eldrid A Baez Matos billed 4,127 services in 27 codes, and Medicare paid $266K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99458 E&M - Miscellaneous | Office | 903 | 75 | $30.13 | $27K |
| 99214 Office E&M - Established | Office | 696 | 318 | $77.15 | $54K |
| 99457 E&M - Miscellaneous | Office | 610 | 81 | $37.56 | $23K |
| 99233 Hospital E&M - Subsequent | Facility | 487 | 186 | $91.17 | $44K |
| 99454 E&M - Miscellaneous | Office | 447 | 69 | $35.85 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 309 | 207 | $12.71 | $3,928 |
| 99232 Hospital E&M - Subsequent | Facility | 161 | 53 | $60.03 | $9,665 |
| 90960 ESRD Related Services (not dialysis) | Office | 139 | 27 | $277.20 | $39K |
| 99223 Hospital E&M - Initial | Facility | 114 | 102 | $130.86 | $15K |
| 99204 Office E&M - New | Office | 78 | 78 | $126.37 | $9,857 |
| 90961 ESRD Related Services (not dialysis) | Office | 48 | 28 | $226.40 | $11K |
| 99453 E&M - Miscellaneous | Office | 28 | 28 | $14.55 | $407 |
| 90962 ESRD Related Services (not dialysis) | Office | 25 | 21 | $158.76 | $3,969 |
| 99215 Office E&M - Established | Office | 21 | 19 | $102.85 | $2,160 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 13 | 13 | $152.19 | $1,979 |
By year: 2022 $153K for 1,475 services; 2023 $229K for 2,419 services; 2024 $266K for 4,127 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eldrid A Baez Matos prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 926 prescriptions and refills. In total Eldrid A Baez Matos wrote 4,119 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 926 | 1,485 | 215 | $830K |
| Kerendia Finerenone | 426 | 755 | 105 | $477K |
| Rayaldee Calcifediol | 379 | 385 | 61 | $457K |
| Mounjaro Tirzepatide | 340 | 388 | 67 | $409K |
| Bumetanide Generic | 260 | 574 | 90 | $11K |
| Furosemide Generic | 138 | 303 | 52 | $662 |
| Lokelma Sodium Zirconium Cyclosilicate | 92 | 132 | 31 | $76K |
| Carvedilol Generic | 87 | 218 | 32 | $731 |
| Potassium Chloride Generic | 74 | 152 | 32 | $1,829 |
| Losartan Potassium Generic | 72 | 177 | 29 | $602 |
| Jardiance Empagliflozin | 67 | 137 | 19 | $79K |
| Ozempic Semaglutide | 65 | 107 | 26 | $80K |
| Allopurinol Generic | 61 | 137 | 19 | $607 |
| Amlodipine Besylate Generic | 60 | 154 | 32 | $306 |
| Tamsulosin Hcl Generic | 54 | 132 | 19 | $874 |
Brand drugs: 2,526 claims; generic drugs: 1,593 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eldrid A Baez Matos $14K ($14K in general payments such as food, travel and fees) from 12 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $12K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 24 | $12K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $389 |
| Amgen Inc. AMGN | 8 | $313 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $272 |
| Vifor Pharma, Inc. | 13 | $252 |
| OPKO Pharmaceuticals, LLC | 7 | $157 |
| Calliditas Therapeutics US Inc. | 7 | $151 |
| GlaxoSmithKline, LLC. GSK | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $102 |
| Scpharmaceuticals Inc. SCPH | 1 | $21.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.